While YY1 promotes tumor growth by stabilizing HIF-1α levels in some types of tumors [24], aberrant expression of YY1 results in ccRCC by increasing the expression of HIF-2α and inhibiting VHL [25]. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.